Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1111/all.16334
dc.identifier.other
WOS:001330750100001
dc.description.volume
dc.description.issue
Publisher
WILEY
DOI
10.1111/all.16334